Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1992-07-02
1994-01-11
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514509, A61K 3113
Patent
active
052781925
ABSTRACT:
The present invention provides a novel method of vasodilator therapy for treating a patient suffering from a condition, comprising long term, continuous administration of an organic nitrite to a patient suffering from the condition in a dosage form capable of delivering a sufficient therapeutic amount of nitrite to the blood stream of the patent thereby providing effective vasodilator therapy for at least 24 hours without development of tolerance in the patient. The method of the invention is useful in treating conditions such as, for example, angina, particularly chronic, stable angina pectoris, ischemic diseases, congestive heart failure, for controlling hypertension and/or impotence in male patients.
Any conventional drug delivery system can be employed in carrying out the method of the invention. The drug delivery system can take virtually as many different forms as there are dosage forms available for delivery of nitrite to a patient. For example, drug delivery systems within the scope of the invention include sublingual, oral and buccal tablets as well as capsules, topical creams and ointments, patches, tapes, spray and intravenous solutions.
REFERENCES:
patent: 3106511 (1963-10-01), Cuttler et al.
patent: 4450175 (1984-05-01), Warshaw
patent: 4615699 (1986-10-01), Gale et al.
patent: 4681584 (1987-07-01), Gale et al.
patent: 4751087 (1988-06-01), Wick
patent: 4956181 (1990-09-01), Bayer et al.
Japanese Laid-Open Patent Publication No. 913 of 1983.
Japanese Laid-Open Patent Publication No. 185,919 of 1988.
Japanese Laid-Open Patent Publication No. 185,920 of 1988.
Japanese Laid-Open Patent Publication No. 156,909 of 1989.
L. A. Crandall, Jr., et al., "Acquired Tolerance To and Cross Tolerance Between the Nitrous and Nitric Acid Esters And Sodium Nitrite In Man," Oct. 6, 1930, pp. 103-119.
G. W. Burggraf, M.D., et al., "Left Ventricular Volume Changes After Amyl Nitrite and Nitroglycerin in Man as Measured By Ultrasound," Jan. 1974, pp. 136-143.
D. T. Mason, M.D., "The Effects of Nitroglycerin and Amyl Nitrite on Arteriolar and Venous Tone in the Human Forearm," Nov. 1965, pp. 755-766.
J. Ahlner, et al., "Organic Nitrate Esters: Clinical Use and Mechanisms of Actions," 1991, pp. 351 and 369.
G. R. Newell, M.D., et al., "Toxicity, Ummunosuppressive Effects and Carcinogenic Potential of Volatile Nitrites: Possible Relationship to Kaposi's Sarcoma," Sep./Oct., 1984, pp. 284-291.
B. Noack, "Mechanisms of Nitrate Tolerance-Influence of the Metabolic Activation Pathways," 1990, pp. 51-55.
E. Noack, et al., "Molecular Mechanisms of Nitrovasodilator Bioactivation," 1991, pp. 37-50.
M. Packer, M.D., FACC, "What Causes Tolerance to Nitroglycering? The 100 Year Old Mystery Continues," 1990, pp. 932-935.
J. Dupuis, M.D., et al., "Tolerance to Intravenous Nitroglycerin in Patients with Congestive Heart Failure: Role of Increased Intravascular Volume, Neurohumoral . . . ," 1990, p. 923.
J. P. Tarburton, et al., "Kinetics of Amyl Nitrite-Induced Hemoglobin Oxidation in Cord and Adult Blood," Mar. 2, 1985, pp. 15-21.
L. C. Green, et al., "Analysis of Nitrate, Nitrite, and [.sup.15 N]Nitrate in Biological Fluids", Feb. 22, 1982, pp. 131-138.
E. M. Dax, et al., "Amyl Nitrite Alters Human In Vitro Immune Function," 1991, pp. 577-587.
P. J. Henry, et al., "Nitrate Tolerance Induced by Nicorandil or Nitroglycerin is Associated with Minimal Loss of Nicorandil Vasodilator Activity," 1990, pp. 365-370.
Hop-Leung Fung, Ph.D., Pharmacokinetic Determinants of Nitrate Action, Jun. 22, 1984, The American Journal of Medicine, pp. 22-26.
Steven Corwin, M.D., James A. Reiffel, M.D., Nitrate Therapy for Angina Pectoris, Mar., 1985, Arch Intern Med-vol. 145, pp. 538-543.
Jonathan Abrams, M.D., Pharmacology of Nitroglycerin and Long-Acting Nitrates, Jul. 10, 1985, The American Journal of Cardiology, vol. 56, pp. 12A-18A.
John T. Flaherty, M.D., Hemodynamic Attenuation and the Nitrate-Free Interval: Alternative Dosing Strategies for Transdermal Nitroglycerin, Amer. Jou. of Card., Dec. 27, 1985, vol. 56, pp. 321-371.
Jonathan Abrams, Chapter 3, Mechanism of Actions of Nitrates, pp. 79-95, 1992.
T. Zimmermann, M. Leitold and R. Yeates, Comparison of isobutyl nitrate and isobutyl nitrite: tolerance and cross-tolerance to glyceryl trinitrate, Eur. Journ. of Pharm., Nov. 6, 1990, pp. 181-184.
Ho-Leung Fung and John Bauer, Effects of chronic glyceryl trinitrate on left ventricular . . . Cardiovascular Research, 1990, pp. 198-203.
Elizabeth Kowaluk and Ho-Leung Fung, Vascular Nitric Oxide-Generating Activities for Organic Nitrites and Organic Nitrates are Distinct, Journal of Pharm., vol. 259, No. 2, pp. 519-525, 1991.
J. Parker, M. D., B. Farrell, RN, T. Fenton, EdD, M. Cohanium, M.D., J. Parker, M.D., Counter-Regulatory Responses . . . Neurohormonal Resp. to Nitrogly. Cir., vol. 84, No. 6, Dec. 1991, pp. 2336-2345.
H. Fung, PhD, S. Chung, PhD, J. Bauer, PhD, S. Chong, PhD, and E. Kowaluk, PhD, Biochemical Mechanism of Organic Nitrate Action, The Amer. Journal of Cardiology, Sep. 1992, vol. 69, pp. 4B-10B.
P. Needleman and E. Johnson, Jr., Mechanism of Tolerance Development to Organic Nitrates, The Journal of Pharmacology, vol. 184, No. 3, 1973, pp. 709-715.
J. Diamond and T. Holmes, Effects of Patassium Chloride and Smooth Muscle Relaxants on Tension and Cyclic Nucleotide Levels in Rat Myometrium, Can. J. Physiol. Pharmacol., vol. 53, 1975, pp. 1099-1107.
S. Katsuki, W. Arnold and F. Murad, Effects of Sodium Nitroprusside, Nitroglycerin, and Sodium Azide on Levels of Cyclic Nucleotides . . . , Journal of Cyclic Nucleotide Res., pp. 239-247, 1977.
F. Murad, C. Mittal, W. Arnold, S. Katsuki and H. Kimura, Guanylate Cyclase: Activation by Azide, Nitro Compounds . . . , Advances in Cyclic Nucleotide Res., 1978, pp. 145-158.
L. Ignarro, H. Lippton, J. Edwards, W. Baricos, A. Hyman, P. Kadowitz and C. Gruetter, Mechanism of Vascular Smooth Muscle Relaxation by Organic Nitrates . . . , Jou. of Phar., vol. 218, No. 3, pp. 739-749, 1981.
J. Bauer and H. Fung, Differential Hemodynamic Effects and Tolerance Properties of Nitroglycerin and an S-Nitrosothiol in Experimental Heart Failure, Journal of Pharm., vol. 256, No. 1, pp. 249-256, 1990.
H. Fung, S. Chong and E. Kowaluk, Mechanisms of nitrate action and vascular tolerance, European Heart Journal, 1989 10, Supplemental A, pp. 2-6.
W. Levy, M.D., R. Katz, M.D., FACC, A Wasserman, M.D., FACC, Methionine Restores the Venodilative Response to Nitroglycerin After the Development of Tolerance, JACC, vol. 17, No. 2, Feb. 1991, p. 474.
R. Katz, M.D., W. Levy, M.D., L. Buff, RN, A. Wasserman, M.D., Prevention of Nitrate Tolerance With Tolerance With Angiotension Converting Enzyme Inhibitors, vol. 83, No. 4, Apr. 1991, pp. 1271-1277.
J. Bauer, MSc and H. Fung, PhD, Concurrent Hydralazine Administration Prevents Nitroglycerine-Induced Hemodynamic Tolerance in Exper. Heart Failure, Brief Rapid Comm. vol. 84, No. 1, Jul. 1991, pp. 35-39.
R. Lange, M. Reid, D. Tresch, M. Keelan, V. Bernhard, G. Coolidge, Nonatheromatous Isch. Heart Dis. following Withdrawal from Chronic Ind. Nitroglycerin Exp., Circulation, vol. XLVI, Oct. 1972, pp. 666-678.
M. Olivari, M.D., P. Carlyle, B.S., T. Levine, M.D., J. Cohn, M.D., FACC, Hemod. and Horm. Resp. to Transdermal Nitro. in Norm. Sub. and in Pat. with Cong. Heart Fail., JACC vol. 2, No. 5, Nov. 1983, 872-8.
Y. Lis, D. Bennett, G. Lambert, D. Robson, A preliminary double-blind study of intravenous nitro. in acute myocardial infarction, Inten. Care Med., 1984, pp. 179-184.
M. Packer, W. Lee, P. Kessler, S. Gottlieb, N. Medina, M. Yushak, Prevention and Reversal of Nitrate Tolerance in Pat. with Cong. Heart Failure, N. E. Jour. of Med., Sep. 24, 1987, vol. 317, No. 13, pp. 799-804.
U. Elkayan, A. Roth, B. Henriquez, L. Weber, D. Tonnemacher, S. Rahimtoola, Hemodyn. and Horm. Eff. High-Dose Trans. Nitro. Pat. with Chron. Con. Heart Fail., Sep. 1985, Amer. Jour. of Card. vol. 56, pp. 555-559.
S. Flaim, Peripheral vascular effects of nitroglycerin in a conscious rat model of failure, Amer. Physiological Soc., pp. H974-H981, 1982.
C. Leier, R. Magorien,
Bauer John A.
Fung Ho-Leung
Friedman S. J.
Jarvis William
The Research Foundation of State University of New York
LandOfFree
Method of vasodilator therapy for treating a patient with a cond does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of vasodilator therapy for treating a patient with a cond, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of vasodilator therapy for treating a patient with a cond will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1631679